Soul Source Unlimited in Santa Fe, NM - CES Unit (Powered by CubeCart)

Welcome Guest [Login | Register]

Shop by Category

Shopping Basket

Your basket is empty.

0Items in cart:
$0.00Total:

View Basket

Featured Product

OXYSILVER Healthguard

Mailing List

To SUBSCRIBE or UNSUBCRIBE from the Newsletter, click the button below.

Language

Location: /Products

CES Unit

Product Information
Cranial Electrotherapy Stimulator
(Health Pax CES Unit)

The CES Unit, is "a device that applies electrical current to a patient`s head to treat insomnia, depression, or anxiety." It "generates an electric current with an amplitude similar to the human body, and sends the mild electrical impulses through ear clips or electrodes behind your ears."

The device small enough to fit it a shirt or pants pocket. It has a small wire that divides into two, ending in padded clips that go on the ears, and delivers a special, brain-friendly frequency of electrical current. Most people enjoy the sensation. If preferred, the current can be adjusted so that it cannot be felt, and the treatment will still be effective. It is safe, gentle, and effective, promoting stability and harmony as well as helping to reduce cravings.

A sampling of research abstracts available on CES

Insomnia
Weiss, M.F. The treatment of insomnia through electrosleep, J Nerv & Ment.Dis. 157(2): 108-120, 1973.

Patients with objectively measured insomnia were selected randomly from volunteers. After pre-treatment baseline (3 nights) 24 CES treatment and simulated treatments in a double blind manor latency of sleep onset was significantly decreased in CES group, and wake time decreased in CES group, but not in sham group. Stage 1 sleep also decreased significantly in CES group. (Modified author abstract)

Long term follow up of insomnia treatment
Cartwright, R.D. & Weiss, M. F. The effects of electrosleep on insomnia revisited, J Nerv & Ment. Dis. 161 (2): 134-137, 1975.

Two year follow up done at U of Ill. of Weiss's. The treatment of patients, with the exception of 1 person, continued to be free of insomnia 2 years later. Of the sham treated group, 4 had difficulty sleeping but 3 of the 5 awoke moderately well rested. (Modified author abstract)

Depression
Shealy, C, et al, Depression: A diagnostic, neurochemical profile and therapy with CES, J of Neuro. & Ortho. Med Surg. 10(4): 319-21, 1989.

Research was conducted with 4 groups: (1) "normal group", (2) intractable chronic pain, (3) chronic pain with depression, and (4) longstanding depression unresponsive to medication. Psychological tests, serotonin and cholinesterace levels were measured pre and post. Depressed patients improved most with treatment; 60% reported improvement, 44% of the pain patients reported improvement. In the depressed patients, after treatment, both serotonin and cholinesterace levels improved significantly. (Modified author abstract).

Anxiety
Schmitt, R. Capo, T. & Boyd, E. CES as a treatment for anxiety in chemically dependent persons. Alcoholism: Clinical and experimental Research. 10(2): 158-160, 1986.

60 substance abusers, mean age 33.9, were given either CES (30), sham CES (10), or (20) no expr. treatment. Four psychological measures administered pre and post. CES and sham patients received 30 min. of treatment daily for 15 days. Treatment t-tests reveal CES patients had significantly greater improvement than did either control group. No placebo effect noted. (Modified author abstract.)

Drug Abuse

Modification of brain wave activity

Braverman, E. & Blum, K. Modification of P300 amplitude and other electrophysiological parameters of drug abuse. Cur Ther Res. 48(4): 586-56, 1990.
Device: HealthPax, 100 Hz, 20% duty cycle, 1.0 mA, no dc bias, square waves, electrodes at left wrist and forehead.

P300 waves have a reduced amplitude in many alcoholics, which does not revert to normal, even after continued abstinence. 13 alcohol and/or drug abusers and 2 staff controls were selected as they entered the clinic for a computerized EEG. All were given 40 minutes of CES between pre and post EEG. There were no significant changes in the controls. Following the CES the patient's P300 amplitude increased significantly (P<.05). The time went from a pretreatment of 308 to 317 msec post-treatment. The amplitude (dV) sent from pretreatment of 7.0 to 9.9 post-treatment. Also there were significant positive shifts in alpha, delta, theta and beta spectra in patients who were abnormal in one or more of these areas prior to CES treatment. It was concluded that CES might be a significant non-drug treatment for the underlying electrophysiological disorder of the drug abuser, because the normalization of these electrophysiological parameters are characteristic of pharmaceutical treatment. (Modified author abstact)

Health Pax CES Unit Specifications

Pulse Selection - 100 Hz.
Amplitude: 10 - 600 micro amps (continuously adjustable)
Wave Shape: Modified Sinusoidal
Waveform: Bipolar asymmetric rectangular
Amplitude: 0-1.5 Ma. (skin resistance considered)
Duty Cycle: 50%
Pulse Duration: 2 milliseconds (20% duty cycle)
Timer Control: 30 min. & 45 min.
Power Source: 9V Batteries (Included)

Shipping is included in the price.

Disclaimer

Price: $299.00 $270.50

Tell a Friend

Product Code: CESU-0001

Quantity: Add to Basket

About Us | Contact Us | Privacy Policy | Terms & Conditions